Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Asia Cannabis Corp. (C:ASIA)

Business Focus: Alternative Medicine

Sep 08, 2020 01:10 pm ET
IIROC Trade Resumption - ASIA
VANCOUVER, BC, Sept. 8, 2020 /CNW/ - Trading resumes in:
Sep 08, 2020 12:35 pm ET
Asia Green Biotechnology Corp. Expands Technology License Agreement with Pathway Rx Inc. by Entering Corresponding Agreement with PNW Biosciences Inc.
CALGARY, AB / ACCESSWIRE / September 8, 2020 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased to announce that it has entered an agreement with Pathway Rx Inc. ("Pathway Rx") and PNW Biosciences Inc. ("PNW") in which the three companies have determined to act collaboratively to affect the clinical development and commercialization of the Cannabis sativa varieties for prevention and for treatment of COVID-19 and other infectious diseases to which Pathway Rx Inc. owns the rights. Both AGB and PNW have previously
Sep 08, 2020 09:23 am ET
IIROC Trading Halt - ASIA
VANCOUVER, BC, Sept. 8, 2020 /CNW/ - The following issues have been halted by IIROC:
Aug 18, 2020 11:41 am ET
IIROC Trade Resumption - ASIA
VANCOUVER, BC, Aug. 18, 2020 /CNW/ - Trading resumes in:
Aug 18, 2020 09:00 am ET
Asia Green Biotechnology Corp. Enters Technology License Agreement with Pathway Rx Inc. for Asia Region and Agrees to Assist in Initiating Clinical Trials
CALGARY, AB / ACCESSWIRE / August 18, 2020 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased to announce that it has entered an agreement with Pathway Rx Inc. ("Pathway Rx") pursuant to which AGB is granted an exclusive license to clinically develop and commercialize the Cannabis sativa varieties to which Pathway Rx Inc. owns the rights for prevention and for treatment of COVID-19 and other infectious diseases. Both companies wish to see those varieties, and possibly other versions of the strains, studied for their effic
Aug 17, 2020 12:38 pm ET
IIROC Trading Halt - ASIA
VANCOUVER, BC, Aug. 17, 2020 /CNW/ - The following issues have been halted by IIROC:
May 19, 2020 02:20 pm ET
Asia Green Biotechnology Corp. Updates Status of Continuing COVID-19 Research Activity with License Partners
CALGARY, AB / ACCESSWIRE / May 19, 2020 / Asia Green Biotechnology Corp. ("ASIA" or the "Company") (CSE:ASIA) announced the following corporate developments today:
Apr 15, 2020 02:29 pm ET
CSE Bulletin: Name Change - Asia Cannabis Corp. (ASIA)
Toronto, Ontario--(Newsfile Corp. - le 15 avril/April 2020) - Asia Cannabis Corp. has announced a name change, Asia Green Biotechnology Corp.
Apr 14, 2020 04:45 pm ET
Asia Cannabis Corp. Announces Official Name Change
Not for Dissemination to U.S. Wire Services or for Dissemination in the United States
Mar 30, 2020 04:00 pm ET
Asia Cannabis Corp. Confirms Patent Application Filed by Swysh Inc. in Relation to Anti-Viral Treatments
CALGARY, AB / ACCESSWIRE / March 30, 2020 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA) announced the following corporate developments today:
Mar 19, 2020 06:30 pm ET
Asia Cannabis Corp. Enters Agreement with Swysh Inc. to Obtain Technology License for Asia Region; Announces Intention to Affect Name Change and Complete Private Placement
CALGARY, AB / ACCESSWIRE / March 19, 2020 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA) announced the following corporate developments today:
Mar 06, 2020 12:25 am ET
Corporate Update and Early Warning Report Issued Pursuant to National Instrument 62-103
Not for distribution to U.S. Newswire Services or for dissemination in the United States.
Sep 30, 2019 09:00 am ET
Asia Cannabis Corp. Commences Activities in Thailand by Strategic Alliance with Ameriseed Group; Announces Intention to Complete Private Placement
CALGARY, AB / ACCESSWIRE / September 30, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA) announced the following corporate developments today:ACC continues to successfully implement its business plan in SE Asia. In addition to its wide-ranging activities in the Kingdom of Cambodia, the Company is pleased to announce that it has entered a Memorandum of Understanding with the AmeriSeed Group ("AmeriSeed"). The purpose of this agreement is to allow ACC and AmeriSeed to collaborate in the pursuit and execution of a business developmen
May 13, 2019 08:15 pm ET
Asia Cannabis Corp. Announces Resignation of Director
CALGARY, AB / ACCESSWIRE / May 13, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that Kenneth McKinnon has submitted his resignation as a director of the Company. Mr. McKinnon has agreed to continue with the Company in a consulting role, and a contract with a two-year term has been executed with him in that regard.
Apr 30, 2019 10:50 pm ET
Asia Cannabis Corp. Announces Appointment of David Pinkman as Senior Executive; Files Audited Financial Statements
CALGARY, AB / ACCESSWIRE / April 30, 2019 / Asia Cannabis Corp. ('ACC' or the 'Company') (CSE:ASIA), announced today that, after receiving the resignation of Johannes Kingma as President and CEO of the Company, David Pinkman has been appointed to fill those roles on an interim basis.
Feb 27, 2019 05:43 pm ET
Asia Cannabis Corp. Announces Grant of Options
CALGARY, AB / ACCESSWIRE / FEBRUARY 27, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that it has granted an aggregate of 550,000 stock options (each, an "Option") to a director of the Company in accordance with the Company's stock option plan. Each Option is exercisable into one common share in the capital of the Company (each, a "Share") at a price of $0.25 per Share for a period of five years from the date of grant. Including this grant of Options, the Company has gra
Feb 21, 2019 12:53 pm ET
Asia Cannabis Corp. Announces Appointment of Dr. Darryl Hudson to Board of Directors
CALGARY, AB / ACCESSWIRE / February 21, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that, subject to regulatory approval, Dr. Darryl Hudson has been elected as a member of the Board of Directors. Dr. Hudson is a principal of InPlanta Biotechnology Inc. and received a PhD in Molecular Biology and Genetics from the University of Guelph in 2010. He has published research in diverse fields including plant biology, genetics, epigenetics, DNA repair mechanisms, and carcinogenesis. He primarily works as a consultant and research
Feb 14, 2019 01:15 pm ET
Asia Cannabis Corp. Announces Execution of Agreement to Acquire Control of Cambodian Company
CALGARY, AB / ACCESSWIRE / February 14, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that, after the successful closing of the Company's IPO and subsequent listing of common shares on the CSE Exchange, ACC has made the first significant steps to initiate hemp-oriented research and development activities in Cambodia with execution of a share purchase agreement pursuant to which the Company will acquire all of the issued shares of a Cambodian private company. Targeted because of its existing and early participation in the he
Jan 31, 2019 07:01 am ET
(PODCAST) NewlyTrading! Asia Cannabis Corp. (ASIA:CSE)
January 31 2019  / TheNewswire /  On this edition of NewlyTrading, Asia Cannabis Corp. (ASIA:CSE)  is an early-stage international agri-technology company centred on the planting, growing, and harvesting of new and valuable strains of hemp in South Asia.  
Jan 28, 2019 09:10 am ET
CSE New Listing - Asia Cannabis Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2019) - Asia Cannabis Corp. (CSE: ASIA) is one of the latest new listing on the Canadian Securities Exchange. The company, an international agri-technology company, will specialize in growing and processing proprietary strains of hemp and bulk cannabidiol in Cambodia and elsewhere in southeast Asia with the ultimate aim to export to the large markets across Asia.
Jan 24, 2019 06:13 pm ET
Asia Cannabis Corp. Announces Listing of Common Shares and Commencement of Trading on the Canadian Securities Exchange
CALGARY, AB / ACCESSWIRE / January 24, 2019 / Asia Cannabis Corp. ("ACC" or the "Company") (CSE:ASIA), announced today that the common shares of the Company have been listed for trading on the CSE. On January 11, 2019, ACC completed its initial public offering of 5,047,000 common shares at the price of $0.25 per common share pursuant to a Prospectus dated October 29, 2018 for gross proceeds of $1,261,750 (the "Offering"). With the completion of that Offering, the Company satisfied the conditions necessary to complete its listing on the CSE and the
Jan 11, 2019 07:02 pm ET
Asia Cannabis Corp. Announces Completion of Initial Public Offering
Calgary, Alberta--(Newsfile Corp. - January 11, 2019) - Asia Cannabis Corp. (CSE: ASIA) ("Asia" or the "Corporation") is pleased to announce that it has completed its initial public offering of 5,047,000 common shares at the price of $0.25 per common share pursuant to a Prospectus dated October 29, 2018 for gross proceeds of $1,261,750 (the "Offering" or the "IPO"). The Corporation will be listed as a hemp research and development company on the Canadian Securities Exchange (the "CSE"). Emerging Equities Inc. (the "Agent") acted as agent under the Offering. The common shares of the Corporation are expected to commence trading on the CSE under the trading symbol "ASIA" once all post-closing documentation has been filed with the CSE, which is expected shortly.